Сравнение

Carbetocin vs. Plecanatid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

37025-55-1

467426-54-6

Молекулярная масса

нет данных

1682 g/mol

Период полувыведения

0.67 h

нет данных

Последовательность

нет данных

Механизм действия

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Plecanatid

Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Carbetocin	Plecanatid
Германия	Рецептурный	Не одобрено
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Carbetocin and Plecanatid?: Carbetocin is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Plecanatid?: The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Plecanatid in Germany and the United States?: Германия: Carbetocin — Рецептурный, Plecanatid — Не одобрено. США: Carbetocin — Не одобрено, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Plecanatid

Германия

Рецептурный

Не одобрено

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Carbetocin and Plecanatid?

Carbetocin is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Plecanatid?

The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Plecanatid in Germany and the United States?

Германия: Carbetocin — Рецептурный, Plecanatid — Не одобрено. США: Carbetocin — Не одобрено, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.